Literature DB >> 31575612

Hide and Seek: Overcoming the Masking Effect of Opioid Antagonists in Activity-Based Screening Tests.

Annelies Cannaert1, Marie Deventer1, Melissa Fogarty2, Amanda L A Mohr2, Christophe P Stove3.   

Abstract

Mesh:

Substances:

Year:  2019        PMID: 31575612     DOI: 10.1373/clinchem.2019.309443

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  4 in total

1.  Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays.

Authors:  Marthe M Vandeputte; Mattias Persson; Donna Walther; Svante Vikingsson; Robert Kronstrand; Michael H Baumann; Henrik Gréen; Christophe P Stove
Journal:  Arch Toxicol       Date:  2022-01-24       Impact factor: 5.153

2.  Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid.

Authors:  Marthe M Vandeputte; Alex J Krotulski; Donna Walther; Grant C Glatfelter; Donna Papsun; Sara E Walton; Barry K Logan; Michael H Baumann; Christophe P Stove
Journal:  Arch Toxicol       Date:  2022-04-28       Impact factor: 6.168

3.  First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass.

Authors:  Marthe M Vandeputte; Nick Verougstraete; Donna Walther; Grant C Glatfelter; Jeroen Malfliet; Michael H Baumann; Alain G Verstraete; Christophe P Stove
Journal:  Arch Toxicol       Date:  2022-04-21       Impact factor: 6.168

4.  Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidine.

Authors:  Tanja M Gampfer; Lea Wagmann; Yu Mi Park; Annelies Cannaert; Jennifer Herrmann; Svenja Fischmann; Folker Westphal; Rolf Müller; Christophe P Stove; Markus R Meyer
Journal:  Arch Toxicol       Date:  2020-04-05       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.